Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001174 · ClinicalTrials.gov registry record
Evaluation of the Genetics of Bipolar Disorder
A clinical trial of Bipolar Disorder, sponsored by National Institute of Mental Health (NIMH).
- Active
- Registry status
- 4,185
- Enrollment target
- 1
- Study location
NCT00001174: Active study of Bipolar Disorder, sponsored by National Institute of Mental Health (NIMH).
NCT00001174 is a study of Bipolar Disorder that is active but no longer recruiting, run by National Institute of Mental Health (NIMH). The registered enrollment target is 4,185 participants, above the 307-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (1263% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001174, a study of Bipolar Disorder, is active but no longer recruiting, sponsored by National Institute of Mental Health (NIMH).
- ACTIVE NOT RECRUITING
- Registry status
- 4,185 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks to identify genes that may affect a person's chances of developing bipolar disorder (BP) and related conditions.
Primary Outcome
Psychiatric diagnosis is based on systematic review of established signs and symptoms, using an instrument designed to elicit retrospective information of known reliability, supplemented with information from family informants, any medical records, and by dimensional symptom measures.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,185 participants |
| Start Date | 1994-08-11 |
What the registry record for NCT00001174 still lists
NCT00001174 is an observational study that tracks outcomes without assigning an intervention. Its 4,185 participants enrollment target places it among the larger protocols in the corpus, above the 307-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (1263% higher).
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT00001174 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001174 about?
NCT00001174 is a clinical study titled "Evaluation of the Genetics of Bipolar Disorder". This study looks to identify genes that may affect a person's chances of developing bipolar disorder (BP) and related conditions.
What is the current status of trial NCT00001174?
This trial is currently active not recruiting. The enrollment target is 4,185 participants. The study started on 1994-08-11.
What conditions does trial NCT00001174 study?
This clinical trial studies the following conditions: Bipolar Disorder.
Who is sponsoring clinical trial NCT00001174?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001174 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001174's enrollment target sits among peer trials
4,185 3rd of 162 higher than 160 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- NCT07209098 · 4,200 participants
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI